Company profile: Accumetrics
1.1 - Company Overview
Company description
- Provider of the VerifyNow System, a comprehensive suite of assays for assessing platelet function, which the company develops, manufactures, and markets.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Accumetrics
Stago
HQ: France
Website
- Description: Provider of automated systems for blood analysis in coagulation and haemostasis education, including the free iHemostasis app in English. A pharmaceutical company with a strong interest in clinical pathology and haemostasis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stago company profile →
Vetex Medical
HQ: Ireland
Website
- Description: Provider of a platform medical device for the venous vascular system—the Vetex Thrombectomy Catheter—designed to speedily extract thrombus in a single session from patients with venous thrombo-embolism.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vetex Medical company profile →
Biomaneo
HQ: France
Website
- Description: Provider of medical analysis kits for the detailed analysis of proteins by mass spectrometry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biomaneo company profile →
Disc Medicine
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for hematologic diseases and rare blood disorders, including Bitopertin, an oral GlyT1 inhibitor for erythropoietic porphyrias and abnormal erythropoiesis; DISC-0974, an injectable monoclonal antibody targeting hemojuvelin (HJV) to suppress hepcidin for anemias of inflammation; and DISC-3405, an injectable monoclonal antibody inhibiting TMPRSS6 to increase hepcidin for polycythemia vera and iron overload.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Disc Medicine company profile →
Veralox Therapeutics
HQ: United States
Website
- Description: Provider of small molecule therapeutics targeting the 12-LOX pathway for thrombosis and Type 1 Diabetes. Products include VLX-1005, a first-in-class drug for treating Heparin-Induced Thrombocytopenia by inhibiting platelet activation through 12-LOX pathway inhibition; VLX-2000 Series under development to protect β cells and improve insulin production; plus an Expanded Access Program for investigational medicines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veralox Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Accumetrics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Accumetrics
2.2 - Growth funds investing in similar companies to Accumetrics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Accumetrics
4.2 - Public trading comparable groups for Accumetrics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →